Neuren Pharmaceuticals Limited ( NURPF) - Stock Earnings
NURPF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | 9.9 million USD | 18.6 million USD |
| 2025Q4 | 10.3 million USD | 24.3 million USD |
| 2026Q2 | 3.3 million USD | 22.9 million USD |
NURPF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 107.0 million USD | 158.0 million USD |
| 2024 | 88.3 million USD | 134.7 million USD |
| 2025 | 20.3 million USD | 43.2 million USD |
| 2026 Est. | — | — |
NURPF
Price: $14.28
52 week price:
Dividend Yield: 0.73%
Earnings Per Share: 0.11 USD
P/E Ratio: 146.36
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.8 billion